BeyondSpring (BYSI) Short term Debt (2021)

BeyondSpring's (BYSI) quarterly Short term Debt came in at $1.6 million in Q4 2021, up 1.1% quarter-over-quarter from $1.6 million in Q3 2021.

Analysis

BeyondSpring (BYSI) Short term Debt (2021) Analysis & Trends

BeyondSpring has disclosed Short term Debt across 1 years of filings, most recently posting $1.6 million for Q4 2021.

In Q4 2021, Short term Debt changed N/A year-over-year to $1.6 million; the TTM figure through Dec 2021 stood at $1.6 million (changed N/A YoY), while the FY2021 annual figure was $1.6 million, changed N/A from the prior year.
Short term Debt came in at $1.6 million for Q4 2021 at BeyondSpring, up from $1.6 million in the prior quarter.
In the past five years, Short term Debt ranged from a high of $2.2 million in Q2 2021 to a low of $1.5 million in Q1 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Johnson & Johnson	641.14 Bn	620.38 Bn	17.26 Bn
2	AbbVie	451.04 Bn	444.47 Bn	12.70 Bn
3	Merck	357.43 Bn	350.29 Bn	12.21 Bn
4	Novartis Ag	266.73 Bn	259.04 Bn	11.24 Bn
5	Pfizer	157.52 Bn	145.82 Bn	10.94 Bn
6	Sanofi	52.14 Bn	44.76 Bn	10.79 Bn
7	Revolution Medicines	42.88 Bn	42.88 Bn	-
8	Incyte	24.70 Bn	20.16 Bn	1.57 Bn
9	United Therapeutics	21.47 Bn	18.80 Bn	683.80 Mn
10	BeyondSpring	31.51 Mn	31.51 Mn	-

Historic Data

Download Data